EUVIMEDEUVIMED entdecken
Crossref

In Situ Cross-Linkable Hyaluronic–Ferulic Acid Conjugate Containing Bucladesine Nanoparticles Promotes Neural Regeneration after Spinal Cord Injury

Farzaneh Sorouri, Parastoo Hosseini, Mohammad Sharifzadeh, Sahar Kiani, Mehdi Khoobi iD

ACS Applied Materials & Interfaces · 2023

DOI: 10.1021/acsami.3c08366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Farzaneh Sorouri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center (MBRC), Faculty of Pharmacy, Tehran University of Medical Science,…. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Spinal Cord Regeneration. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Institute for Medical Research Development, Royan Institute for Stem Cell Biology and Technology, Tehran University of Medical Sciences and Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesSpinal Cord RegenerationAnimalsRatsBucladesineAxonsGliosisAntioxidantsHydrogelsCoumaric Acids

Stichwörter der Autor:innen

Spinal cord injuryencapsulated bucladesinefunctional recoveryhyaluronic acid−ferulic acid conjugateinjectable hydrogelmyelinated axon regeneration

Substanzen

BucladesineAntioxidantsHydrogelsferulic acidCoumaric Acids

Autor:innen und Institutionen

  • Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center (MBRC), Faculty of Pharmacy, Tehran University of Medical Science, Tehran 14176-14411, Iran.
  • Department of Brain and Cognitive Sciences, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran 16656-59911, Iran.
  • Pharmaceutical Quality Assurance Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran 14176-14411, Iran.
  • Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14176-14411, Iran.
  • Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14176-14411, Iran.

ORCID-Profile: Mehdi Khoobi

Förderung

  • National Institute for Medical Research Development
  • Royan Institute for Stem Cell Biology and Technology
  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Sorouri, F., Hosseini, P., Sharifzadeh, M., Kiani, S., & Khoobi, M. (2023). In Situ Cross-Linkable Hyaluronic–Ferulic Acid Conjugate Containing Bucladesine Nanoparticles Promotes Neural Regeneration after Spinal Cord Injury. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c08366

Vancouver

Sorouri F, Hosseini P, Sharifzadeh M, Kiani S, Khoobi M. In Situ Cross-Linkable Hyaluronic–Ferulic Acid Conjugate Containing Bucladesine Nanoparticles Promotes Neural Regeneration after Spinal Cord Injury. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c08366

BibTeX
@article{Sorouri2023,
  author = {Sorouri, Farzaneh and Hosseini, Parastoo and Sharifzadeh, Mohammad and Kiani, Sahar and Khoobi, Mehdi},
  title = {In Situ Cross-Linkable Hyaluronic–Ferulic Acid Conjugate Containing Bucladesine Nanoparticles Promotes Neural Regeneration after Spinal Cord Injury},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  doi = {10.1021/acsami.3c08366}
}
Kostenlos starten →